10. Bilusic, M., et al., Phase I t rial of HuMax- IL8 (BMS-986253), an anti- IL-8 monoclonal antibody, in patients with me tastatic or unresecta ble solid tumors. J Immunother Cancer, 2019. 7(1): p. 240.